We examine gold’s likely direction and the best ways to profit from its gyrations. Read More

Although the drugmaker’s treatment for hepatitis C has shown great promise during clinical trials, investors still have time to take advantage of this stock before shares head higher in anticipation of the drug’s approval. Read More

The stock’s struggles with excessive debt and dilution echo the lessons from the infamous Mississippi Bubble Read More

Most people make the wrong decisions about their Social Security benefits and in doing so leave a lot of money on the table. Read More

Bond insurer MBIA has rallied big of late on a favorable court ruling and settlement hopes. But big risks remain. Read More

Does your advisor genuinely understand exchange-traded funds? For that matter, do you? Here’s how to protect your portfolio from ETF ignorance. Read More

The stock of 3D Systems sold off after reporting strong fourth-quarter earnings, whereas competitor Stratasys saw its stock jump after reporting a very-similar earnings report. The differing treatment by investors is unjustified. Read More

A brand new exchange-traded note (ETN) offers a cash dividend to gold investors. But buyers beware: the risks usually outweigh the rewards.  Read More

Overproduction in the prolific US shale plays has produced another short-term commodity casualty: ethane. Read More

The retailer’s strong recent earnings and upbeat forecast were well-received, but the share price remains a bargain.  Read More